BridGene Biosciences Achieves the Second Preclinical Milestone in Takeda Collaboration ...Middle East

PR Newswire - News
BridGene Biosciences Achieves the Second Preclinical Milestone in Takeda Collaboration
IMTAC™ platform identifies novel targets and small molecules for the development of drugs to treat a broad spectrum of neurological disorders SAN JOSE, Calif., Aug. 28, 2023 /PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company that uses proprietary chemoproteomics...

Hence then, the article about bridgene biosciences achieves the second preclinical milestone in takeda collaboration was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BridGene Biosciences Achieves the Second Preclinical Milestone in Takeda Collaboration )

Apple Storegoogle play

Last updated :

Also on site :